The gluconeogenic capacity of the placenta is debated [43,44]; however, down-regulation of CARHSP1 in the placenta, indicated by the apparent down-regulation in STBEVs, or globally in GDM could increase gluconeogenesis and thus contribute to the hyperglycaemic characteristic of GDM. The gene discussed is CARHSP1; the disease is gestational diabetes.